Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent polyradiculoneuropathy and PMP22 defects.

Yuh-Jen Wang1, Koa-Pei Kao, Kon-Ping Lin

  • 1Department of Health, Keelung Hospital, Executive Yuan, Taiwan, ROC.

Journal of the Chinese Medical Association : JCMA
|December 6, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

Multidisciplinary Approaches for Diagnosing Underrecognized Transthyretin Amyloidosis in Real-World Practice.

Acta Cardiologica Sinica·2026
Same author

Use of technetium-99m-pyrophosphate single-photon emission computed tomography/computed tomography in monitoring therapeutic changes of RNA interference therapeutics in patients with hereditary transthyretin amyloid cardiomyopathy.

Journal of the Formosan Medical Association = Taiwan yi zhi·2024
Same author

Patisiran, an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis: Sub-analysis in Taiwanese patients from the APOLLO study.

Journal of the Formosan Medical Association = Taiwan yi zhi·2024
Same author

Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.

Neurology and therapy·2023
Same author

Reduced-penetrance Huntington's disease-causing alleles with 39 CAG trinucleotide repeats could be a genetic factor of amyotrophic lateral sclerosis.

Journal of the Chinese Medical Association : JCMA·2023

Genetic analysis of the peripheral myelin protein 22 (PMP22) gene revealed no mutations in patients experiencing recurrent Guillain-Barré syndrome (GBS) or chronic relapsing polyneuropathies (CRP). These findings suggest PMP22 is not a cause of these recurrent inflammatory neuropathies.

Area of Science:

  • Neurology
  • Genetics
  • Immunology

Background:

  • Inflammatory neuropathies involve immunologic factors, but mechanisms of recurrent Guillain-Barré syndrome (GBS) and chronic relapsing polyneuropathies (CRP) remain unclear.
  • Hereditary neuropathy with liability to pressure palsy (HNPP), linked to PMP22 gene mutations, can present as recurrent polyradiculoneuropathy.

Purpose of the Study:

  • To investigate the potential role of the PMP22 gene in patients with recurrent GBS and CRP.
  • To determine if PMP22 gene alterations are associated with recurrent inflammatory neuropathies.

Main Methods:

  • Analyzed the PMP22 gene in 4 patients with recurrent polyradiculoneuropathies (2 GBS, 2 CRP) between 1993-2003.
  • Extracted genomic DNA from peripheral lymphocytes and performed molecular detection for PMP22 deletion.

Related Experiment Videos

Main Results:

  • No duplication, deletion, or point mutation in the PMP22 gene was detected in the studied patients.
  • The PMP22 gene showed no genetic alterations in individuals with recurrent GBS or CRP.

Conclusions:

  • PMP22 gene deletion is not implicated in the pathogenesis of recurrent GBS and CRP in this patient cohort.
  • The genetic basis for recurrent GBS and CRP likely lies outside the PMP22 gene.